DK0712426T3 - Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf - Google Patents

Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Info

Publication number
DK0712426T3
DK0712426T3 DK94922905.8T DK94922905T DK0712426T3 DK 0712426 T3 DK0712426 T3 DK 0712426T3 DK 94922905 T DK94922905 T DK 94922905T DK 0712426 T3 DK0712426 T3 DK 0712426T3
Authority
DK
Denmark
Prior art keywords
fluorochromes
preparation
fluorescent latex
latex
fluorescent
Prior art date
Application number
DK94922905.8T
Other languages
Danish (da)
English (en)
Inventor
Sophie Vaslin
Joel Richard
Dominique Teychenne
Frederic Ricchiero
Dan Lerner
Original Assignee
Prolabo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolabo Sa filed Critical Prolabo Sa
Application granted granted Critical
Publication of DK0712426T3 publication Critical patent/DK0712426T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/10—Encapsulated ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94922905.8T 1993-07-12 1994-07-11 Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf DK0712426T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308573A FR2707658B1 (fr) 1993-07-12 1993-07-12 Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie.

Publications (1)

Publication Number Publication Date
DK0712426T3 true DK0712426T3 (da) 1997-12-22

Family

ID=9449186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94922905.8T DK0712426T3 (da) 1993-07-12 1994-07-11 Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Country Status (10)

Country Link
US (1) US5716855A (no)
EP (1) EP0712426B1 (no)
JP (1) JPH09504041A (no)
CA (1) CA2167072C (no)
DE (1) DE69403663T2 (no)
DK (1) DK0712426T3 (no)
ES (1) ES2104405T3 (no)
FR (1) FR2707658B1 (no)
NO (1) NO308253B1 (no)
WO (1) WO1995002635A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5578498A (en) 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
JP3338616B2 (ja) * 1996-09-05 2002-10-28 富士通株式会社 蛍光体層の形成方法及び蛍光体ペースト
CA2306501C (en) * 1997-10-14 2011-03-29 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same
JP2002504689A (ja) 1998-02-18 2002-02-12 デイド・ベーリング・インコーポレイテッド 複数の検体の検出において使用するための化学ルミネセンス組成物
IL141759A0 (en) * 1998-09-03 2002-03-10 Trellis Bioinformatics Inc Multihued labels
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US6703248B1 (en) 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US20070128732A1 (en) * 2003-07-02 2007-06-07 Lucille Beaudet Scintillator composition for a radioassay, and method for its use
US7407816B2 (en) * 2004-05-07 2008-08-05 Gentius, Inc Isoelectric particles and uses thereof
WO2006027738A1 (en) * 2004-09-10 2006-03-16 Philips Intellectual Property & Standards Gmbh Compounds and methods for combined optical-ultrasound imaging
EP1872128A4 (en) * 2005-04-20 2008-09-03 Becton Dickinson Co MULTIPLEX MICROPARTICLE SYSTEM
US7939613B2 (en) * 2005-04-22 2011-05-10 The Hong Kong University Of Science And Technology Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
NO20053373D0 (no) * 2005-07-11 2005-07-11 Rikshospitalet Radiumhospitale Multicolored Particles.
CN102300885A (zh) 2009-02-09 2011-12-28 默克专利有限公司 用于电泳显示器的有色颗粒
WO2010089060A2 (en) 2009-02-09 2010-08-12 Merck Patent Gmbh Particles for electrophoretic displays
WO2010089057A2 (en) 2009-02-09 2010-08-12 Merck Patent Gmbh Particles for electrophoretic displays
JP2012517486A (ja) 2009-02-09 2012-08-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 電気泳動ディスプレイのための着色粒子
GB2475226A (en) * 2009-11-03 2011-05-18 Genetic Analysis As Universal Prokaryote 16S ribosome PCR primer pair
GB201021399D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
GB201021397D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Diagnosis of Crohn's disease
GB201102693D0 (en) 2011-02-16 2011-03-30 Genetic Analysis As Method for identifying neonates at risk for necrotizing enterocolitis
US9227181B2 (en) 2011-09-13 2016-01-05 Basf Corporation Catalyst to increase propylene yields from a fluid catalytic cracking unit
EP2984114B1 (en) 2013-04-12 2017-03-15 Merck Patent GmbH Particles for electrophoretic displays
EP3233944B1 (en) 2014-12-19 2019-09-04 Merck Patent GmbH Particles for electrophoretic displays
KR20190042641A (ko) * 2016-08-31 2019-04-24 세키스이가가쿠 고교가부시키가이샤 진단약용 형광 입자 및 그것을 사용한 면역 측정 시약
CN111363539A (zh) * 2020-04-30 2020-07-03 上海思滤科技有限公司 一种单分散多色发光微球及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342739A (en) * 1979-01-09 1982-08-03 Fuji Photo Film Co., Ltd. Novel material for immunological assay of biochemical components and a process for the determination of said components
US5073497A (en) * 1989-06-30 1991-12-17 Caribbean Microparticles Corporation Microbead reference standard and method of adjusting a flow cytometer to obtain reproducible results using the microbeads
EP0280556B1 (en) * 1987-02-27 1994-08-10 EASTMAN KODAK COMPANY (a New Jersey corporation) Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
US5607864A (en) * 1992-04-07 1997-03-04 Societe Prolabo Fluorescent latices having very low detection thresholds for fluorescent emission
US5264960A (en) * 1992-05-08 1993-11-23 At&T Bell Laboratories Optical wavelength shifter
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5393527A (en) * 1993-01-04 1995-02-28 Becton, Dickinson And Company Stabilized microspheres and methods of preparation

Also Published As

Publication number Publication date
DE69403663T2 (de) 1998-01-02
NO960123L (no) 1996-03-12
FR2707658B1 (fr) 1995-11-24
NO960123D0 (no) 1996-01-11
ES2104405T3 (es) 1997-10-01
NO308253B1 (no) 2000-08-21
EP0712426A1 (fr) 1996-05-22
CA2167072A1 (fr) 1995-01-26
JPH09504041A (ja) 1997-04-22
WO1995002635A1 (fr) 1995-01-26
EP0712426B1 (fr) 1997-06-04
US5716855A (en) 1998-02-10
FR2707658A1 (fr) 1995-01-20
CA2167072C (fr) 2008-10-28
DE69403663D1 (de) 1997-07-10

Similar Documents

Publication Publication Date Title
DK0712426T3 (da) Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf
UA27809C2 (uk) Літак, переважно літак великої місткості
FI931278A0 (fi) Polymerer, som innehaoller sulfogrupper
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
FI891438A (fi) Foerfarande foer framstaellning av farmaceutiska sammansaettningar som inverkar i synnerhet pao det kardiovaskulaera systemet.
FI921279A (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI905663A0 (fi) Foerfarande foer erhaollande av pyridazinderivat, vilka aer anvaendbara som lignder av acetylkolinaktiga receptorer.
NO960364L (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO900741D0 (no) Tris-hydroxymethyl-lavere-alkanestere som fettimitasjoner.
DK539087A (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK135988A (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
FI892214A0 (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
ITRM930697A0 (it) Composti azoici, loro preparazione e loro impiego come coloranti dispersi. (caso 150-5673).
BR9600370A (pt) Benzenossulfoniluréias e-tiouréias substituídas processo para a sua preparação seus usos e medicamento contendo as mesmas
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
BR9600779A (pt) Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento
NO910039D0 (no) Ikke-beskadigende overhalings- og fullfoeringsfluid.
BR9606955A (pt) Heterocicloalquenos substituísos
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
FI914146A0 (fi) Foerfarande foer behandling av metaller som avgjutit medelst sprutning.
ITRM930621A0 (it) Composti monoazoici, loro preparazione e loro impiegop come coloranti reattivi. (caso 150-5640)
DK225189A (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
NO901758D0 (no) Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse.
FI906269A (fi) 2,19-metylenoxi- och 2,19-metylentio -tvaerbundna steroider som aromatas- och 19-hydroxylasinhibitorer.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.